−0.010AUD
−7.00 MAUD
714.09 M
About PRESCIENT THERAPEUTICS LIMITED
Sector
Industry
CEO
Steven Yatomi-Clarke
Website
Headquarters
South Melbourne
Founded
1986
ISIN
AU000000PTX3
FIGI
BBG000J4RZJ3
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded on May 22, 1986 and is headquartered in South Melbourne, Australia.
$PTX - Prescient Therapeutics - Strong news on cancer treatmentPopped up on my volume alerts and bought on the pullback. Went as high as 10 cents on some pretty strong news!
ANNOUNCEMENT:
================================
Melbourne, Australia (10 December 2018): Clinical-stage oncology company Prescient Therapeutics Limited (ASX: PTX; Prescient) is pleased to
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PTX is 0.057 AUD — it has decreased by 3.39% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PRESCIENT THERAPEUTICS LIMITED stocks are traded under the ticker PTX.
PRESCIENT THERAPEUTICS LIMITED is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
PTX stock is 5.26% volatile and has beta coefficient of −0.09. Check out the list of the most volatile stocks — is PRESCIENT THERAPEUTICS LIMITED there?
PTX earnings for the last quarter are −0.43 AUD per share, whereas the estimation was −0.01 AUD resulting in a −4.20 K% surprise. The estimated earnings for the next quarter are −0.01 AUD per share. See more details about PRESCIENT THERAPEUTICS LIMITED earnings.
Yes, you can track PRESCIENT THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
PTX stock has fallen by 5.00% compared to the previous week, the month change is a 9.62% rise, over the last year PRESCIENT THERAPEUTICS LIMITED has showed a 38.71% decrease.
PTX net income for the last quarter is −3.62 M AUD, while the quarter before that showed −4.12 M AUD of net income which accounts for 12.25% change. Track more PRESCIENT THERAPEUTICS LIMITED financial stats to get the full picture.
Today PRESCIENT THERAPEUTICS LIMITED has the market capitalization of 47.51 M, it has increased by 10.34% over the last week.
No, PTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRESCIENT THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PRESCIENT THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PRESCIENT THERAPEUTICS LIMITED stock shows the sell signal. See more of PRESCIENT THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.